Document is current
Any future updates will be listed below
-
Authors
Mahmood, Hanya https://orcid.org/0000-0001-7159-0368
Shephard, Adam
Hankinson, Paul
Bradburn, Mike
Araujo, Anna Luiza Damaceno
Santos-Silva, Alan Roger
Lopes, Marcio Ajudarte
Vargas, Pablo Agustin
McCombe, Kris D.
Craig, Stephanie G.
James, Jacqueline https://orcid.org/0000-0002-6945-6060
Brooks, Jill
Nankivell, Paul https://orcid.org/0000-0003-4664-6117
Mehanna, Hisham
Rajpoot, Nasir https://orcid.org/0000-0002-4706-1308
Khurram, Syed Ali
-
Funding
Funding for this research was provided by:
DH | National Institute for Health Research (NIHR300904)
Cancer Research UK (C63489/A29674, C63489/A29674, C63489/A29674)
RCUK | Medical Research Council
AstraZeneca
- License Information
-
More Information
Article History
Received: 15 April 2023
Revised: 2 September 2023
Accepted: 12 September 2023
First Online: 27 September 2023
Competing interests
: NR is the Director and CSO of Histofy, an AI start-up in the area of computational pathology. SAK is a shareholder of Histofy. The remaining authors do not declare any competing interests.
: Ethical approval was obtained from the West Midlands Research Ethics Committee (18/WM/0335).
